Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALBO | PSTX | NUVB | ||
| Company | Albireo Pharma Inc | Poseida Therapeutics Inc | Nuvation Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 44.90 | 9.38 | 2.63 | ||
| High | 44.90 | 9.49 | 2.76 | ||
| Low | 43.99 | 9.36 | 2.57 | ||
| Last | 44.15 | 9.45 | 2.68 | ||
| Change | -0.10 | +0.04 | -0.01 | ||
| % Change | -0.23% | +0.43% | -0.37% | ||
| Volume | 1,241,200 | 2,108,200 | 9,242,000 | ||
| 20-Day Average Volume | 635,260 | 2,739,300 | 2,683,365 | ||
| Previous Close | 44.25 | 9.41 | 2.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 44.18 | 8.75 | 2.78 | ||
| 20-Day Raw Stochastic | 43.90% | 98.11% | 31.48% | ||
| 20-Day Relative Strength | 72.09% | 84.61% | 49.60% | ||
| Weighted Alpha | +16.30 | -10.51 | +6.29 | ||
| Today's Opinion | 88% Buy | 100% Buy | 40% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 40% Sell | ||
| Last Month's Opinion | 100% Buy | 88% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.28% since 02/23/23 | -0.63% since 12/13/24 | +2.68% since 12/13/24 | ||
| Low | 43.53 on 02/24/23 | 9.36 on 12/20/24 | 2.51 on 12/18/24 | ||
| High | 44.90 on 03/02/23 | 9.56 on 12/17/24 | 2.87 on 12/17/24 | ||
| 1-Month | |||||
| %Chg | -0.90% since 02/02/23 | +247.43% since 11/20/24 | +3.88% since 11/20/24 | ||
| Low | 43.31 on 02/23/23 | 2.65 on 11/21/24 | 2.51 on 12/18/24 | ||
| High | 45.23 on 02/03/23 | 9.58 on 12/12/24 | 3.05 on 11/29/24 | ||
| 3-Month | |||||
| %Chg | +85.66% since 12/02/22 | +180.42% since 09/20/24 | -4.29% since 09/20/24 | ||
| Low | 17.78 on 12/27/22 | 2.32 on 10/31/24 | 2.00 on 10/10/24 | ||
| High | 45.23 on 02/03/23 | 9.58 on 12/12/24 | 3.08 on 11/11/24 | ||
| 6-Month | |||||
| %Chg | +156.84% since 09/02/22 | +256.60% since 06/20/24 | -11.55% since 06/20/24 | ||
| Low | 16.02 on 09/07/22 | 2.32 on 10/31/24 | 2.00 on 10/10/24 | ||
| High | 45.23 on 02/03/23 | 9.58 on 12/12/24 | 3.97 on 07/31/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 913,949 | 923,964 | 902,000 | ||
| Shares Outstanding, K | 20,701 | 97,774 | 336,567 | ||
| Annual Sales | 40,580,000 | 64,700,000 | 0 | ||
| Annual Net Income | -34,030,000 | -123,430,000 | -75,800,000 | ||
| Last Quarter Sales | 9,830,000 | 71,750,000 | 730,000 | ||
| Last Quarter Net Income | -37,800,000 | 20,240,000 | -41,210,000 | ||
| 60-Month Beta | 1.03 | 1.64 | 1.46 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.89 on 11/08/22 | 0.21 on 11/07/24 | -0.15 on 11/06/24 | ||
| Latest Earnings Date | 03/07/23 | 11/14/24 | 11/07/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||